SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950142-24-001424
Filing Date
2024-05-24
Accepted
2024-05-24 16:47:57
Documents
2
Period of Report
2024-05-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT es240464228_3-lappe.html 3  
1 OWNERSHIP DOCUMENT es240464228_3-lappe.xml 3 1688
2 EXHIBIT 24.1 es240464228_ex2401.htm EX-24.1 10220
  Complete submission text file 0000950142-24-001424.txt   13479
Mailing Address 11622 EL CAMINO REAL SUITE 100 SAN DIEGO CA 92130
Business Address
Lappe Mark (Reporting) CIK: 0001366074 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42031 | Film No.: 24985201

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Issuer) CIK: 0002007919 (see all company filings)

IRS No.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)